Yong Yu - Mar 14, 2025 Form 4 Insider Report for GENELUX Corp (GNLX)

Role
VP, Clinical Trial Operations
Signature
/s/ Sean Ryder, Esq., Attorney-in-Fact
Stock symbol
GNLX
Transactions as of
Mar 14, 2025
Transactions value $
$0
Form type
4
Date filed
4/17/2025, 04:56 PM
Previous filing
Dec 20, 2024
Next filing
May 13, 2025
SEC
View on sec.gov

Transactions Table

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs are fully vested as of March 14, 2025.